KDventures AB (STO:KDV.B)

Market Cap	166.14M -40.8%
Revenue (ttm)	1.67M -9.1%
Net Income	-193.86M
EPS	-0.72
Shares Out	659.28M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,095,419
Average Volume	1,804,596
Open	0.2700
Previous Close	0.2700
Day's Range	0.2000 - 0.2700
52-Week Range	0.2000 - 1.3440
Beta	0.37
RSI	38.37
Earnings Date	Mar 20, 2026

About KDventures AB

KDventures AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2003
• Employees: 8
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: KDV.B

Financial Performance

In 2025, KDventures AB's revenue was 1.67 million, a decrease of -9.09% compared to the previous year's 1.84 million. Losses were -193.86 million, 2293.0% more than in 2024.